FOLH1 and metastatic malignant neoplasm in the lymph nodes: No significant difference in the median SUVpeak of the PSMA-avid prostate lesions was found between patients with and without lymph-node metastases (SUVpeak = 6.4, IQR 3.8–10.9, vs. 6.7, IQR 5.2–18.6) (p = 0.46).